gastroesophageal reflux
Scope
Date
~
-
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
Latest News
- 1 Mirae Asset Global Investments’ managed asset surpasses $288 billion
- 2 Google partners with Samsung, Gentle Monster to revive smart glasses ambitions
- 3 Korean financial firms launch global IR blitz to woo foreign capital
- 4 KIC bets on Asian real estate; eyes residential, data centers
- 5 NPS boosts allocation to direct lending, secondaries